Pharmacologic treatments for covid-19 patients
Inhaled Nitric Oxide vs Standard care
This comparison will not be updated. Last search date 28 Feb, 2022.
Outpatients
Forest plots
(last update: 2022-04-29)
Hospitalized patients
Forest plots
(last update: 2021-05-28)
To access all information :
You can print it as a pdf. You can also click on each forest plot with your right mouse button and download.
Permanent URL for this comparison: https://covid-nma.com/living_data/index.php?comparison=381
Back to your research
Trial | Funding | Comparisons | Design | Participants | Sample size | Overall risk of bias Highest assessment |
Full description | |
---|---|---|---|---|---|---|---|---|
Treatment 1 | Treatment 2 | |||||||
N/A Winchester S, J Infect, 2021 Full text 00251-6/fulltext Commentary |
Private |
Nitric Oxide Nasal Spray |
Placebo |
RCT | Patients with confirmed COVID-19 (mild) isolated and treated at a single center in the UK. | N=80 |
Some concerns Details |
|
ISRCTN16806663 Moni M, IMD, 2022 Full text Full text Commentary |
Public/non profit |
Inhaled Nitric Oxide |
Standard care |
RCT | Patients with confirmed COVID-19 (severe) admitted to a single center in India. | N=29 |
High Details |